Trials / Completed
CompletedNCT02378324
Effect of Fee on Attendance in Cervical Cancer Screening
Effect of Fee on Attendance in Cervical Cancer Screening-results From ScreenFee a Swedish Population Based Randomised Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,124 (actual)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- Female
- Age
- 23 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Several reasons can explain non-attendance in cervical cancer screening. In low resource settings the attendance is even lower. The effect of fee as contributing reason of non attendance has not been studied before why the investigators decided to study this in a low resource setting as a randomised trial.
Detailed description
Non-attendance in the cervical cancer screening programme is the most important factors why Swedish women contract the disease. Low attendance rate is observed in districts with low socioeconomic resources. Several reasons can explain this, including the existence of a fee. A low attendance rate in low resource districts is also noticed in Gothenburg, Sweden. After multiple interventions the coverage has slightly increased. None of the interventions included the aspect of the fee. The investigators decided to study the effect of fee abolishment in a randomized control trial emanating from the regular cervical cancer-screening program. Method: Randomized Control Trial (RCT). Women in low resource areas of Gothenburg, due for screening, January-July 2013, were randomised to receive an offer of a free test or receiving the regular invitation stating the regular fee of 100 Swedish kronor (SEK) (≈11 €). Power calculation has shown 80 % power to detect an increase in participation of 20% at 1972 participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Screening without fee | All women in three districts in Gothenburg, Sweden, that were eligible for invitation in the regular screening program were individually randomized by computer program in two parallel arms 1:1. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2015-03-04
- Last updated
- 2015-03-04
Source: ClinicalTrials.gov record NCT02378324. Inclusion in this directory is not an endorsement.